Telangana Attracts 54,000 Cr, Rises in Global Life Sciences

India Pharma Outlook | Wednesday, 20 August 2025

With investments of over Rs. 54,000 crore in the last year alone, Telangana has once again established itself as a global leader in the life sciences, and the city is currently listed among the top 7 life sciences clusters worldwide.

Since the establishment of the new government, the state has drawn over Rs. 54,000 crore in total investments in the fields of pharmaceuticals, biotechnology, cell and gene therapy, medical devices, vaccines, and digital healthcare, all supported by strong policy support, industry-friendly infrastructure, and strategic alliances. Leading international and Indian companies in sectors like sterile injectables, biosimilars, biologics, AI/ML, and advanced healthcare services might create over 2 lakh jobs as a result of these investments.

The Board Meeting of Telangana Life Sciences convened today and was attended by D. Sridhar Babu, Minister for IT, industries & commerce, electronics & communications, and legislative affairs, who proceeded to review progress in the life sciences sector. Special chief secretary Sanjay Kumar, as well as VC&MD TGIIC Shashanka, CEO of Telangana Lifesciences Shakthi M. Nagappan, chairman of DRL Satish Reddy, chairman of Laurus Labs Satya Chava, and others also attended the meeting.

Also Read: Impact of Modern Technology on the Indian Life Sciences Sector

According to D Sridhar Babu, minister for information technology, electronics & communications, industries & commerce and legislative affairs in the state of Telangana, “Telangana has emerged as a global epicentre for innovation-led life sciences and is now home to over 2,000 life sciences companies. The progress made in the last year reflects our strategic commitment to creating a future-ready, knowledge-driven ecosystem. Hyderabad’s emergence as one of the top 7 global life sciences clusters is a direct outcome of Telangana’s progressive policies, robust infrastructure, and talent-rich ecosystem. This is a result of our focussed efforts and I take this opportunity to congratulate our team on the significant growth.”

on the deck

Most Viewed

Related Articles


© 2025 India Pharma Outlook. All Rights Reserved.